Neumann-Haefelin C, Brinker G, Uhlenküken U, Pillekamp F, Hossmann K-A, Hoehn M
Department of Experimental Neurology, Max-Planck Institute for Neurological Research, Cologne, Germany.
Stroke. 2002 May;33(5):1392-8. doi: 10.1161/01.str.0000014619.59851.65.
Thrombolytic treatment of stroke carries the risk of hemorrhagic transformation. Therefore, the potential of MRI for prediction of recombinant tissue plasminogen activator (rtPA)-induced bleeding is explored to identify patients in whom rtPA treatment may provoke such complications.
Spontaneously hypertensive rats (SHR) (n=9) were submitted to middle cerebral artery (MCA) clot embolism, followed 3 hours later by intra-arterial infusion of 10 mg/kg rtPA. Untreated SHR (n=9) were infused with saline. MRI imaging was performed before treatment and included apparent diffusion coefficient (ADC), T2, and perfusion mapping and contrast enhancement with gadolinium-DTPA. The distribution of intracerebral hemorrhages was studied 3 days later by histological staining.
Clot embolism led to the rapid decline of ADC in the territory of the occluded artery. Tissue lesion volume derived from ADC imaging increased by 155+/-69% in the untreated animals and by 168+/-87% in the treated animals (P=NS), determined on the histological sections after 3 days. This same lesion growth in both groups indicated absence of therapeutic effect after 3-hour treatment delay. Hemorrhagic transformations were significantly more frequent in treated SHR (P<0.05). In untreated rats, hemorrhages were found in the border zone of the ischemic territory; in treated animals, hemorrhagic transformations occurred in the ischemic core region. rtPA-induced hemorrhages were predicted by a disturbance of the blood-brain barrier in 3 of 4 animals before treatment by Gd-DTPA contrast enhancement but not by ADC, T2, or perfusion imaging. The region of contrast enhancement colocalized with subsequent bleeding in these animals.
The disturbance of blood-brain barrier but not of other MR parameters allows risk assessment for hemorrhagic transformation induced by subsequent thrombolytic treatment.
脑卒中的溶栓治疗存在出血转化风险。因此,探讨磁共振成像(MRI)预测重组组织型纤溶酶原激活剂(rtPA)诱导出血的潜力,以识别rtPA治疗可能引发此类并发症的患者。
将9只自发性高血压大鼠(SHR)进行大脑中动脉(MCA)血栓栓塞,3小时后动脉内输注10mg/kg rtPA。9只未治疗的SHR输注生理盐水。治疗前进行MRI成像,包括表观扩散系数(ADC)、T2以及灌注成像和钆喷酸葡胺增强扫描。3天后通过组织学染色研究脑出血的分布。
血栓栓塞导致闭塞动脉区域ADC迅速下降。根据3天后组织学切片测定,未治疗动物中由ADC成像得出的组织病变体积增加了155±69%,治疗动物中增加了168±87%(P=无显著差异)。两组相同的病变增长表明3小时治疗延迟后无治疗效果。治疗的SHR中出血转化明显更频繁(P<0.05)。在未治疗的大鼠中,出血发生在缺血区域的边缘带;在治疗的动物中,出血转化发生在缺血核心区域。在4只动物中,有3只在治疗前通过钆喷酸葡胺增强扫描显示血脑屏障破坏可预测rtPA诱导的出血,但ADC、T2或灌注成像不能预测。这些动物中增强区域与随后的出血部位一致。
血脑屏障的破坏而非其他磁共振参数可用于评估后续溶栓治疗诱导出血转化的风险。